CDK5 is a novel regulatory protein in PPARgamma ligand-induced antiproliferation.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  International Journal of Oncology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 16327995
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ciglitazone induces early cellular proliferation and NF-kappaB transcriptional activity in colon cancer cells through p65 phosphorylation.

  2005cited by this paper
• Involvement of Cdk5/p25 in Digoxin-triggered Prostate Cancer Cell Apoptosis*

  2004cited by this paper
• Phosphorylation of PPARgamma via active ERK1/2 leads to its physical association with p65 and inhibition of NF-kappabeta.

  2003cited by this paper
• Phosphorylation of MEK1 by cdk5/p35 Down-regulates the Mitogen-activated Protein Kinase Pathway*

  2002cited by this paper
• The role of the Cdk5--p35 kinase in neuronal development.

  2001cited by this paper
• Deregulation of Cdk5 in a mouse model of ALS: toxicity alleviated by perikaryal neurofilament inclusions.

  2001cited by this paper
• Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration

  1999cited by this paper
• Differentiation and reversal of malignant changes in colon cancer through PPARγ

  1998cited by this paper
• The nuclear eicosanoid receptor, PPARgamma, is aberrantly expressed in colonic cancers.

  1998cited by this paper
• The cdk5/p35 kinase is essential for neurite outgrowth during neuronal differentiation.

  1996cited by this paper
• The Sec1 Family: A Novel Family of Proteins Involved in Synaptic Transmission and General Secretion

  1996cited by this paper
• Activity and expression pattern of cyclin-dependent kinase 5 in the embryonic mouse nervous system.

  1993cited by this paper

• A kinase of many talents: non-neuronal functions of CDK5 in development and disease

  2020cites this paper
• Crosstalk between Cdk5/p35 and ERK1/2 signalling mediates spinal astrocyte activity via the PPARγ pathway in a rat model of chronic constriction injury

  2019cites this paper
• CDK5 in oncology: recent advances and future prospects.

  2017cites this paper
• The Emerging Role of Cdk5 in Cancer.

  2016cites this paper
• CDK5 functions as a tumor promoter in human colorectal cancer via modulating the ERK5–AP-1 axis

  2016cites this paper
• Preoperative low dose NSAID treatment influences the genes for stemness, growth, invasion and metastasis in colorectal cancer

  2014cites this paper
• Proteomic Analysis of the Human Cyclin-dependent Kinase Family Reveals a Novel CDK5 Complex Involved in Cell Growth and Migration*

  2014cites this paper
• CDK5-induced p-PPARγ(Ser 112) downregulates GFAP via PPREs in developing rat brain: effect of metal mixture and troglitazone in astrocytes

  2014cites this paper
• Steered Molecular Dynamics Simulations for Studying Protein-Ligand Interaction in Cyclin-Dependent Kinase 5

  2014cites this paper
• Impact des ligands de PPARs, et leurs dérivés, sur les cellules cancéreuses coliques humaines : modifications des statuts redox et glycolytique

  2014cites this paper
• Pdx-1 modulates endoplasmic reticulum calcium homeostasis in the islet beta cell via transcriptional enhancement of SERCA2b

  2014cites this paper
• Proteomic Analysis of the Human CDK Family Reveal s a Novel CDK5 Complex Involved in Cell Growth and Migration

  2014cites this paper
• The role of Cdk5 in neuroendocrine thyroid cancer.

  2013cites this paper
• The Role of Peroxisome Proliferator-Activated Receptors in Colorectal Cancer

  2012cites this paper
• A Functional Variant of IC 53 Correlates with the Late Onset of Colorectal Cancer

  2011cites this paper
• A Functional Variant of IC53 Correlates with the Late Onset of Colorectal Cancer

  2011cites this paper
• PPARs are a unique set of fatty acid regulated transcription factors controlling both lipid metabolism and inflammation☆

  2011cites this paper
• Regulation of Androgen Receptor and Prostate Cancer Growth by Cyclin-dependent Kinase 5*

  2011cites this paper
• Characterization of a novel human CDK5 splicing variant that inhibits Wnt/β-catenin signaling

  2010cites this paper
• Pharmacogenomic approach for the identification of novel determinants of acquired resistance to oxaliplatin in colorectal cancer

  2009cites this paper
• RNAi screen of the druggable genome identifies modulators of proteasome inhibitor sensitivity in myeloma including CDK5.

  2009cites this paper
• Estudi farmacogenòmic per a la identificació de gens implicats en la resposta i l'adquisició de resistència a oxaliplatí en el càncer colorrectal

  2008cites this paper
• Identification and chromosome mapping of loci predisposing to colorectal cancer that control Wnt/beta-catenin pathway and progression of early lesions in the rat.

  2007cites this paper
• Expression of Peroxisome Proliferator-Activated Receptor-γ in Colon Cancer: Correlation with Histopathological Parameters, Cell Cycle-Related Molecules, and Patients’ Survival

  2007cites this paper
• A novel cycloheptapeptide exerts strong anticancer activity via stimulation of multiple apoptotic pathways in caspase-3 deficient cancer cells.

  2007cites this paper
• Neuroprotective effect of TNFalpha against the beta-amyloid neurotoxicity mediated by CDK5 kinase.

  2007cites this paper
• International Union of Pharmacology. LXI. Peroxisome Proliferator-Activated Receptors

  2006cites this paper